Christopher A Lamb

Etrolizumab as induction therapy for ulcerative colitis: a randomised, controlled, phase 2 trial

Séverine Vermeire, Sharon O’Byrne, Mary Keir et al. · The Lancet · 2014 · 449 citations · Full text

Infliximab is associated with attenuated immunogenicity to BNT162b2 and ChAdOx1 nCoV-19 SARS-CoV-2 vaccines in patients with IBD

Nicholas A. Kennedy, Simeng Lin, James Goodhand et al. · Gut · 2021 · 275 citations · Full text

British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic

Nicholas A. Kennedy, Gareth‐Rhys Jones, Christopher A Lamb et al. · Gut · 2020 · 255 citations · Full text

Human milk oligosaccharide DSLNT and gut microbiome in preterm infants predicts necrotising enterocolitis

A Masi, Nicholas D. Embleton, Christopher A Lamb et al. · Gut · 2020 · 205 citations · Full text

Exploring the genetic architecture of inflammatory bowel disease by whole-genome sequencing identifies association at ADCY7

Yang Luo, Katrina M. de Lange, Luke Jostins et al. · Nature Genetics · 2017 · 174 citations · Full text

Autoimmune Disease, Genetic Epidemiology, Gastroenterology +10